JORDAN M TYMESON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ALBANY, NY NPI 1942071923

General Payments — all program years on this page

$770.64

  • Category: General Payments
  • Program years: PY2024
  • Record count: 15
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $770.64 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $770.6415

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Amgen Inc. $223.617
Acerta Pharma LLC $170.924
Ardelyx, Inc. $122.881
CALLIDITAS THERAPEUTICS US INC. $119.041
Boehringer Ingelheim Pharmaceuticals, Inc. $114.341
Retrophin, Inc. $19.851

By program year

Program yearAmountRecords
2024 $770.6415

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1104254053 AstraZeneca Pharmaceuticals LP $20.96 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104472622 AstraZeneca Pharmaceuticals LP $18.70 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105448593 AstraZeneca Pharmaceuticals LP $16.06 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105715464 AstraZeneca Pharmaceuticals LP $115.20 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117403584 Amgen Inc. $15.34 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117403586 Amgen Inc. $4.04 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117403588 Amgen Inc. $21.20 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117403590 Amgen Inc. $24.82 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117403592 Amgen Inc. $19.11 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117403594 Amgen Inc. $17.26 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117705988 Amgen Inc. $121.84 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118242779 Boehringer Ingelheim Pharmaceuticals, Inc. $114.34 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141515811 CALLIDITAS THERAPEUTICS US INC. $119.04 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146748755 Ardelyx, Inc. $122.88 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149913168 Travere Therapeutics, Inc. $19.85 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.